Present at one of the largest events in the field, the company will showcase solutions that raise analytical standards and strengthen confidence in results.
From October 29 to November 1, 2025, the Brazilian Congress of Hematology, Hemotherapy and Cellular Therapy (HEMO 2025) will take place at the Transamérica Expo Center in São Paulo (SP). Organized by the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH), the event is recognized as the third largest Hematology congress in the world, consolidating Brazil’s leadership in the global scientific landscape.
Over the course of four days, national and international experts will share innovative perspectives and globally relevant experiences, addressing topics such as Hemotherapy, Cellular Therapy & BMT, Onco-Hematology, Pediatric Hematology, Hemostasis & Thrombosis, Anemias, Flow Cytometry, Laboratory Hematology, Palliative Care, among others.
Controllab Exhibition
At HEMO 2025, attendees will be able to visit the Controllab stand and explore quality control solutions that enhance analytical standards and reinforce the recognition of laboratory services.
The company’s portfolio covers several areas that support hemotherapy services, transfusion testing, and related laboratory analyses. Some of these include:
The complete catalog for External Quality Control (Proficiency Testing) and Internal Quality Control is available at https://controllab.com/en/catalog/.
Controllab’s participation in HEMO 2025 reaffirms its commitment to promoting result reliability across different analytical segments, enhancing the overall efficiency of the sector.
Secure your spot and check out the full program on the official event website: https://hemo.org.br/hemo2025
